The Cureus Journal of Medical Science is proud to introduce the MR-Guided Radiation Therapy: Clinical Applications & Experiences case report publishing competition.
MR-Guided Radiation Therapy represents a fundamental change in the way radiation dose is planned, guided, and delivered. Leveraging the ability to quickly perform daily on-table MR-guided plan adaptations, while also providing automated, real-time soft-tissue tracking and gating, a new frontier of precision radiation medicine is rapidly emerging.
Specific to MR-guided radiotherapy, this program seeks to document related applications and clinical experiences. To foster educational awareness, our goal is to share the results with the radiation oncology, medical oncology and medical physics communities. To encourage dissemination, all published materials will be Open Access and indexed with PubMed Central.
Program administration has been enabled through the financial support of the ViewRay. Article selection, editorial review, peer review, publication, and competition winner determination are strictly independent of the sponsor.
Peer Review Panel
All article submissions will undergo an independent pre-publication peer review conducted by a world-class team of experts.
Ben J. SlotmanM.D., Ph.D. | Radiation Oncology
Radiation Oncology, VU University Medical Center, Amsterdam, NLD
Percy LeeM.D., Associate Professor | Radiation Oncology
Department of Radiation Oncology, University of California Los Angeles, Los Angeles, USA
David A. JaffrayPh.D., Professor | Medical Physics
Department of Radiation Oncology, Princess Margaret Cancer Centre
Indrin J. ChettyPh.D. | Radiation Oncology
Radiation Oncology, Henry Ford Health System, Detroit, USA
Paul KeallPh.D., Professor | Medical Physics
Radiation Physics Laboratory, Sydney Medical School
Eric A. MellonM.D., Ph.D., Assistant Professor | Radiation Oncology
Department of Radiation Oncology, Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami, Miami, USA
Jun ItamiM.D., Ph.D. | Radiation Oncology
Department of Radiation Oncology, National Cancer Center Hospital, Tokyo
Maria A. ThomasM.D., Ph.D., Assistant Professor | Radiation Oncology
Department of Radiation Oncology, Washington University School of Medicine in St. Louis
Hong-Gyun WuM.D., Ph.D., Professor | Radiation Oncology
Department of Radiation Oncology, Seoul National University College of Medicine
Jan LagendijkPh.D., Professor | Radiation Oncology
Department of Radiotherapy, University Medical Center Utrecht
C. David FullerM.D., Ph.D., Associate Professor | Radiation Oncology
Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center
John E. BayouthPh.D., Professor | Radiation Oncology
Department of Human Oncology, University of Wisconsin School of Medicine and Public Health, Madison, USA | Department of Human Oncology, University of Wisconsin - Madison, Madison, USA
The competition has ended and all articles have been published. Scores as of 5:00pm PT on May 8, 2018 determined the winning articles (after proper review by Cureus staff). Because SIQ scoring is an ongoing process, relative scores may change over time.
Competition entry and article submission is entirely free. Eligible entrees include case reports and case series only. Submissions should aim for a 1,000 – 1,200 word target, with a 2,500 word maximum. A limit of five references is strongly encouraged (10 reference maximum). All submitted work must be previously unpublished and should not be under consideration for publication elsewhere.
Maximum of 3 submissions per submitting author.
All articles must be submitted and formatted via the template-driven, self-publishing Cureus platform. Authors are encouraged to include supporting animations and videos within their article submissions. For additional information on publishing with Cureus, please refer to our Author Guide.
- All clinical studies must be compliant with applicable regulatory, ethics / IRB, and other rules governing protection of human subjects.
- All non-clinical studies must be compliant with applicable AAUC, AAALAC, and other related regulations.
- This program is not intended to promote or otherwise encourage unapproved, un-cleared use of products or any product for unapproved new use.
- This program in no way promotes or purports to encourage any research that is not in compliance with any local, federal, or other applicable governing laws.
Statement of Independence
- Cureus Publishing Competitions are intended to encourage medical discovery and document clinical experiences – be they positive, negative, or neutral – and foster broader educational outreach through Open Access publication that is free to both authors and readers.
- Article submissions must adhere to the described “call for articles” and are open to any and all related manufacturer or vendor technologies.
- As a firewall to ensure objective and credible science, article selection, editorial review, peer review and publication are strictly independent of the sponsoring company.
- Winning articles are determined exclusively via peer review panel and community crowdsourced scoring. Neither the sponsoring company, nor Cureus, can determine the competition outcome.
Three Cureus Scientific Excellence™ prizes will be awarded to the published articles that receive the highest Cureus SIQ™ (Scholarly Impact Quotient™) rating:
1st Place: $3,000 USD
2nd Place: $2,000 USD
3rd Place: $1,000 USD
Awards include either a cash distribution or equivalent donation made to the winning article author's charity of choice.
Subsequent to a formal editorial and peer review, published articles undergo SIQ scoring - Cureus’ unique crowdsourced, secondary peer-review process. In addition to measuring engagement, SIQ allows the community-at-large to rate the quality of individual articles. Reviewers assign scores from 1 to 10 on criteria including clarity and rationale, clinical importance, study design and methods, data analysis, novelty of conclusions and quality of presentation.
As engagement and scoring are critical to winning, authors are highly encouraged to share their published articles via social media and email.
- Tuesday, November 28, 2017 – Competition begins; articles may now be submitted
- Tuesday, March 6, 2018 – Article submission deadline @ 5:00 pm PT
- Tuesday, April 10, 2018 – Peer & editorial review of all eligible articles concludes
- Tuesday, May 8, 2018 – Competition crowdsourced review (SIQ) concludes @ 5:00 pm PT
- Thursday, May 10, 2018 – Winning article announced